Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Disease area: Pulmonary vascular diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
O. Yucel, E. Tozkoparan, A. Gunal, E. Macit, H. Caylak, S. Gurkok, K. Kavakli, H. Gul, O. Genc (Ankara, Turkey). The effect of proanthocyanidin on re-expansion pulmonary edema in rat. Eur Respir J 2008; 32: Suppl. 52, 300

Member's Comments

No comment yet.

Related content which might interest you: Morphological characteristics and mechanism of a rat model of reexpansion pulmonary edema Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels Year: 2018 Hypoxia-induced pulmonary edema Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 Two cases of noncardiogenic pulmonary edema? Source: Eur Respir J 2004; 24: Suppl. 48, 278s Year: 2004 The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Effect of curcumin on inflammation in experimental pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007 Diagnosing pulmonary oedema and permeability Source: International Congress 2016 – New tools for the early diagnosis of acute respiratory distress syndrome Year: 2016 Estimation of antibiotic effect on the development of bleomycin-induced pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis. Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Antifibrosic effects of sulforaphane in human lung fibroblasts from idiopathic pulmonary fibrosis Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2011 Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Interstitial pressure and lung oedema in chronic hypoxia Source: Eur Respir J 2011; 37: 943-949 Year: 2011 Changes in pulmonary surfactant composition during bleomycin-induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 397s Year: 2006 Antioxidant and anti-inflammation effect of GHK-Cu in bleomycin-induced pulmonary fibrosis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Determining the aetiology of pulmonary oedema by the oedema fluid-to-plasma protein ratio Source: Eur Respir J 2010; 35: 331-337 Year: 2010 Mechanisms of hypoxia-induced oedema reabsorption Source: Annual Congress 2005 - An update on the mechanisms of pulmonary oedema formation and reabsorption Year: 2005 The impact of emphysema in pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 153-157 Year: 2013 The early drainage of pneumothorax avoids re-expansion pulmonary oedema and reduces tensile stress Source: Annual Congress 2010 - Infections and pleural problems Year: 2010 Occult alveolar haemorrhage in pulmonary veno-occlusive disease Source: Eur Respir J 2006; 27: 108-113 Year: 2006